Drugs against blood pressure and heart failure origin of China, it turns cancer Trigger

JAKARTA – The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have issued warnings about the dangers of taking blood pressure medication and the Heart failure, valsartan.Obat Zhejiang Huahai Pharmaceutical Company contains N-nitrosodimethylamine substances that can trigger cancer.Tipso.id, who launched antaranews, Chinese manufacturers of drugs for high blood pressure said that 39, he made a global withdrawal, after the regulators of the United States and Europe have warned of the contamination of substances that may

The European Medicines Agency (EMA) has issued a warning regarding the supply of valsartan active ingredients produced by Zhejiang Huahai Pharmaceutical Company, based in East China and listed on the Shanghai Stock Exchange, Thursday (07/05/2018). The US Food and Drug Administration (FDA) releases a similar notice a week later, saying Huahai has decided to suspend deliveries and begin withdrawals on Friday (13/7/2018). it's volunteered to start withdrawing products containing the production of Huahai Valsartan after the FDA statement. As reported by Nytimes, the generic drug valsartan may have been contaminated with N-nitrosodimethylamine (NDMA), one of the substances considered to be carcinogens or cancer triggers. The EMA and the FDA warn of the presence of N-nitrosodimethylamine (NDMA), which is likely to cause cancer if used long-term. "We have carefully evaluated the drugs containing valsartan sold, and we have found that the valsartan sold by these specialty companies does not meet our safety standards," said Dr. Janet Woodbad, director of the Valuation Center of Valsartan. the FDA. and drug research. Drug Type Valsartan is a generic medicine used primarily for the treatment of high blood pressure and congestive heart failure. The FDA does not mention any products containing valsartan in the United States. The existence of the NDMA is unexpected and seems to be related to the changes in the He added. ***